baber/WOPTO huggingface dataset:
Patent JP-3499565-B2 (JP)
IPC: A47C7/70
Filed: 1995-08-29
Granted: 2004-02-23
Abstract: PCT No. PCT/IB95/00706 Sec. 371 Date Apr. 21, 1997 Sec. 102(e) Date Apr. 21, 1997 PCT Filed Aug. 29, 1995 PCT Pub. No. WO96/08985 PCT Pub. Date Mar. 28, 1996A writing tablet assembly for attachment to a chair comprising: a writing tablet; a frame for supporting the writing tablet and for attachment to a chair, and a swivel joint interposed between the writing tablet and the frame to define a first predetermined plane of rotation of the swivel joint with respect to the frame and a second predetermined plane of rotation of the writing tablet with respect to the swivel joint.
Patent JP-3162076-B2 (JP)
IPC: C08F8/28
Filed: 1992-12-04
Granted: 2001-04-25
Abstract: A process for producing mixed poly(vinyl acetal)s containing butyral acetal groups and long chain acetal groups derived from one or more aldehydes containing at least six C atoms, by conducting an acetalization reaction forming long chain acetal groups in the substantial absence of butyraldehyde until gel break occurs, adding butyraldehyde after gel break and continuing acetalization until the desired reaction endpoint is reached. Reaction temperature is from about 40  DEG C up to the boiling point of water at the pressure of the acetalization reaction and preferably between about 75  DEG C and about 98  DEG C.
Patent JP-3433231-B2 (JP)
IPC: G01N33/74
Filed: 1995-11-15
Granted: 2003-08-04
Abstract: Method for screening the risk for gastric cancer using, in combination, the determination of serum pepsinogen I, gastrin-17 and the supporting determination of Helicobacter pylori antibodies from blood serum, in order to detect either atrophy of the corpus area, atrophy of the antrum area or atrophy of the mucosa of the whole stomach as well as a causative Helicobacter pylori infection, whereby the risk for gastric cancer can be evaluated and the necessary gastroscopy and follow-up can be planned.
Patent JP-3334087-B2 (JP)
IPC: A61K31/40
Filed: 1991-09-06
Granted: 2002-10-15
Abstract: PCT No. PCT/US91/06447 Sec. 371 Date Apr. 23, 1993 Sec. 102(e) Date Apr. 23, 1993 PCT Filed Sep. 6, 1991 PCT Pub. No. WO92/04315 PCT Pub. Date Mar. 19, 1992.This invention relates to bicyclic aryl compounds having selective LTB4 antagonist properties and comprising an amido substituent, a substituent group having a terminal carboxylic acid or derivative thereof and a lipophilic substituent, and to methods for the treatment of disorders which result from LTB4 activity and pharmaceutical compositions including such compounds.
Patent JP-3392416-B2 (JP)
IPC: A61F5/44
Filed: 1993-03-11
Granted: 2003-03-31
Abstract: In an absorbent article, such as a diaper or incontinence briefs, an elastic member (60) comprising a net-like elastic substrate (62) to which fibers (64, 66) are pre-bonded provides for a breathable elastic for use as a side- a waist- or leg elastic. The fibers that are bonded to the net-like substrate, for instance by hydro-entangling, ensure a soft and comfortable contact with the wearer's skin. In the side panels of the absorbent article, the elastic members have a large freedom of stretch without buckling taking place, thus reducing chances of leakage. When the elastic member is located between the topsheet and the backsheet, a strong connection of topsheet to backsheet is established using a relatively small amount of adhesive.
Patent JP-3488468-B2 (JP)
IPC: G01G11/08
Filed: 1995-12-05
Granted: 2004-01-19
Abstract: PCT No. PCT/EP95/04786 Sec. 371 Date Jun. 5, 1997 Sec. 102(e) Date Jun. 5, 1997 PCT Filed Dec. 5, 1995 PCT Pub. No. WO96/18088 PCT Pub. Date Jun. 13, 1996In order to improve the metering accuracy, especially with a strongly fluctuating feed material supply, a method and an apparatus for continuous, gravimetric metering and mass flow determination of flowable materials are proposed, wherein the output of the metering device (8) is regulated with a time offset to match the set-point flow rate in dependence on the instantaneous mass flow determined at the flowmeter (4).
Patent JP-4222638-B2 (JP)
IPC: B24C1/04
Filed: 1998-09-01
Granted: 2009-02-12
Abstract: The apparatus comprises a storage vessel (19) for abrasive particles, a source of pressurised carrier fluid and a first conduit (11) to convey at least a major proportion of the incoming carrier fluid to a nozzle (16). A second conduit (9) connects the source of carrier fluid to an inlet of the storage vessel (19) and a third conduit (18) connects its outlet to the nozzle (16). A switching device (6) is selectively operable either to allow a minor proportion of incoming carrier fluid to flow through the second conduit (9) to the storage vessel (19), or to direct all of the carrier fluid through the first conduit (11). When a minor proportion of carrier fluid is directed through the second conduit (9), abrasive particles in carrier fluid are discharged from storage vessel (19) into the third conduit (18). When all of the carrier fluid is directed through the first conduit (11), fluid from the second conduit is entrained, thereby reversing fluid flow in the second (9) and third (18) conduits. The source of pressurised carrier fluid is preferably an intensifier plunger pump which has bearing surfaces (203) to guide a reciprocating cylinder (204). One end of the reciprocating cylinder (204) is closed and carries a plunger (201) and a connection (215) for driving fluid to enter the cylinder for the pump return stroke. The other end of the cylinder (204) has a piston (205) movable within a fixed cylinder (206) on which driving fluid acts during the pump delivery stroke.
Patent JP-3855071-B2 (JP)
IPC: C12P21/04
Filed: 1994-03-09
Granted: 2006-12-06
Abstract: The invention provides a clinically useful monoclonal antibody which can recognize the conserved region of the V3-PND region of a glycoprotein antigen (gp120) having a molecular weight of about 120,000 Da and contained in the coat of a human immunodefiency virus (HIV) and which can neutralize a wide variety of HIV variants, or a fragment of the above antibody, and chimera and humanized antibodies derived from the above antibody. It is possible to prepare a monoclonal antibody having the activity of neutralizing various HIV variants by using as the immunogen several types of peptides having a PND tip region containing a GPGR sequence having a high conservability in the PND region of the gp120 of an HIV. It is possible to obtain a chimera antibody or an altered antibody having an anti-HIV neutralization activity effective for clinical application by transplanting a fragment of a gene coding for the variable region of the above monoclonal antibody or the complementarity-determining region of that region to a human antibody gene.
Patent JP-3294857-B2 (JP)
IPC: B01D53/26
Filed: 1997-10-29
Granted: 2002-06-24
Abstract: An advantageous configuration of an adsorption medium in a drying plant is described. At least one cartridge containing the adsorption medium for a gas to be dried is removably disposed in a container of the drying plant. A pressure prevails between the adsorption medium and the cartridge such that the adsorption medium remains stationary in the cartridge, in particular even under changing operating and/or environmental conditions. Using the cartridge enables the adsorption medium to be changed rapidly and safely on site. In addition, the invention ensures a high quality of gas drying, in particular without the added risk of the particles being released. Different cartridges can also be used for different adsorption media and can therefore be optimized to suit the most varied of drying plants.
Patent JP-3103599-B2 (JP)
IPC: C04B111/62
Filed: 1995-12-29
Granted: 2000-10-30
Abstract: PCT No. PCT/FR95/01758 Sec. 371 Date Jun. 27, 1997 Sec. 102(e) Date Jun. 27, 1997 PCT Filed Dec. 29, 1995 PCT Pub. No. WO96/20901 PCT Pub. Date Jul. 11, 1996The invention relates to a self-levelling fluid mortar including calcium sulphate, granulates, lime, water and either a silica and a compound containing alumina or a pozzuolana, and to a screed obtained from said fluid mortar. It also relates to the combined use of lime and either of a silica and of a compound containing alumina or a pozzuolana to increase the mechanical strength and reduce the water sensitivity of a screed.
Patent JP-3990462-B2 (JP)
IPC: E06B1/32
Filed: 1997-11-14
Granted: 2007-10-10
Abstract: A window, in particular for mounting in an inclined roof surface, comprising a frame structure and a relative thereto openable sash structure with an insulating pane (6), the frame and the sash structures comprising top, bottom and side members (21-24) in the form of solid profiles which are for the major part made from a thermally well insulating material. For providing a good heat-transmission from the interior side of the sash structure to border areas of the insulating pane a passive heat bridge has been established at least in the areas (30, 31) around the corners of the sash bottom member (21) and the adjacent side members (24), said heat bridge being of a well heat-conducting material and established in connection with or through said bottom and side members (23, 24) of the sash structure.
Patent JP-3839047-B2 (JP)
IPC: B65D47/14
Filed: 1995-04-13
Granted: 2006-11-01
Abstract: The invention concerns a process for manufacturing a tube from plastic. The body of the tube has an outlet aperture smaller in diameter than the tube body itself, and a cap is provided which can be fitted over the outlet aperture to close it. According to the invention, the tube body and cap are connected by a hinge and manufactured in one stage by injection moulding, the tube body undergoing a further process in a second stage to alter its shape.
Patent ES-2527338-B2 (ES)
Title: Sistema de unión lateral mediante bridas para perfiles en I ó H
Inventor: CABALEIRO NUNEZ MANUEL
IPC: E04B1/24
Filed: 2013-07-22
Granted: 2015-12-07
Abstract: La presente invención consiste en un sistema de unión lateral a 90º de perfiles metálicos en I o H que emplea unos soportes de unión con rasgados (Figura 1) en ambas caras en contacto con los perfiles a unir. Estos rasgados posibilitan la unión de distintos tamaños de perfiles I o H estándar. Para ello se necesita, a parte de los mencionados soportes, unas grapas de fijación con sus tornillos, tuercas y arandelas correspondientes. Con este sistema se realizaría la unión lateral a 90º del tipo viga transversal a ala del pilar empleando para ello perfiles metálicos normalizados del tipo I o H.
Patent ES-2549685-B2 (ES)
Title: Sistema antimicrobiano
Inventor: BARAT BAVIERA JOSÉ MANUEL
IPC: A61P31/04
Filed: 2015-07-21
Granted: 2016-06-23
Abstract: La presente invención se refiere a un sistema antimicrobiano que comprende partículas de soporte funcionalizadas con al menos un compuesto antimicrobiano de origen natural. Las partículas se seleccionan preferiblemente del grupo constituido por partículas mesoporosas de óxido de silicio con un tamaño de partícula comprendido entre 0,01 y 7 {mi}m y un tamaño de poro comprendido entre 1 y 20 nm, y partículas de óxido de silicio amorfo con un tamaño de partícula comprendido entre 0,01 y 30 {mi}m, mientras que el compuesto antimicrobiano se selecciona preferiblemente del grupo constituido por carvacrol, cinamaldehído, perillaldehído, eugenol, timol, vainillina, ácido gálico y ácido ferúlico.
Patent ES-2651161-B2 (ES)
Title: Procedimiento para la producción y almacenamiento de hidrógeno mediante deshidrogenación catalítica, y uso de un catalizador de un metal de transición anclado sobre un soporte de un material de carbono para la obtención de hidrógeno mediante reacciones de deshidrogenación catalítica
Inventor: MATA MARTÍNEZ JOSÉ ANTONIO
IPC: C01B32/182
Filed: 2017-07-11
Granted: 2018-08-13
Abstract: La presente invención se refiere a un procedimiento para la producción y almacenamiento de hidrógeno mediante deshidrogenación catalítica basado en el uso de un catalizador de un metal de transición anclado sobre un soporte de un material de carbono. Adicionalmente, la presente invención también se refiere al uso de un catalizador de un metal de transición anclado sobre un soporte de un material de carbono para la obtención de hidrógeno mediante reacciones de deshidrogenación catalítica, preferiblemente, para el uso de dicho hidrógeno obtenido en una celda de combustible o un motor de combustión.
Patent AU-2002248276-B2 (AU)
Title: Fiber optic circuit board connector
Inventor: TOURNE JOSEPH A A M
IPC: G02B6/30
Filed: 2001-10-29
Granted: 2006-07-06
Abstract: An optical connector for use in multilayer electro-optic circuit boards. An electro-optical back plane circuit board uses both electrical and optical connectors to carry signals in both electrical and light form. The optical connector employs redundant alignment features to provide for reliable connectivity between plug in boards and the electro-optic back plane. A process is of forming the back plane and other multilevel circuit boards so as to embed optical connectors is disclosed.
Patent AU-2002307526-B2 (AU)
Title: Ocular diagnosis of alzheimer's disease
Inventor: GOLDSTEIN LEE E
IPC: G01N33/53
Filed: 2002-04-25
Granted: 2006-08-24
Abstract: The invention features a method of diagnosing or providing a prognosis regarding the state of Alzheimer's Disease in a mammal by contacting an ocular tissue with a detectably-labeled compound, which binds to an amyloid protein. An increase in binding of the compound to the ocular tissue compared to a normal control level of binding indicates that the mammal is suffering from or is at risk of developing Alzheimer's Disease.
Patent AU-2002307543-B2 (AU)
Title: Use of rare earth compounds for the prevention of kidney stone disease
Inventor: IDZAN STEFAN R
IPC: A61K33/244
Filed: 2002-04-22
Granted: 2006-04-27
Abstract: A pharmaceutical composition comprises a salt of a rare earth metal (S1) and at least one nontoxic counterion (C1). (S1) Is optionally hydrated. ACTIVITY : Nephrotropic; Uropathic. MECHANISM OF ACTION : Oxalate Absorption Inhibitor. Stock sodium oxalate solution (50 ml) containing sodium chloride (8.5 g/l) was adjusted to either pH 3 or pH 7. Prior to the addition of lanthanum carbonate, a 2 ml sample was taken as a zero time point sample. The volume of buffer was made up to 50 ml, pH was adjusted and lanthanum carbonate was added so that a concentration of 0.1 M was present in the 50 ml of either pH 3 or pH 7 phosphate/oxalate buffer. A timer was started and 2 ml samples were removed at pre-determined time intervals over twenty minutes and analyzed. A phosphorus assay was performed as given in Sigma procedure 670. The results indicated that even in the presence of 10-fold excess phosphate, lanthanum carbonate bind oxalate.
Patent AU-2002367190-B2 (AU)
Title: Pyrimidotriazines as phosphatase inhibitors
Inventor: SETTI LINA QUATTROCCHIO
IPC: C07D487/04
Filed: 2002-12-27
Granted: 2006-10-05
Abstract: The invention relates to pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B.
Patent AU-2004292386-B2 (AU)
Title: Combustible mosquito coil or stick
Inventor: DEVI KUBERAN SANGITA
IPC: A01N53/00
Filed: 2004-11-04
Granted: 2011-06-23
Abstract: A combustible coil or stick for controlling mosquitoes is disclosed containing an insecticidally effective amount of bifenthrin.
Patent AU-2005212479-B2 (AU)
Title: Carcinoembryonic antigen fusion proteins and uses thereof
Inventor: AURISICCHIO LUIGI
IPC: A61K39/00
Filed: 2005-02-03
Granted: 2009-09-10
Abstract: Polynucleotides encoding carcinoembryonic antigen (CEA) fusion proteins are provided, the CEA fusion proteins comprising a CEA protein, or functional variant thereof, fused to a substantial portion of an immunoenhancing element. The polynucleotides of the present invention can elicit an immune response in a mammal, which, in preferred embodiments, is stronger than the immune response elicited by a wild-type CEA. The gene encoding CEA is commonly associated with the development of human carcinomas. The present invention provides compositions and methods to elicit or enhance immunity to the protein product expressed by the CEA tumor-associated antigen, wherein aberrant CEA expression is associated with a carcinoma or its development. This invention specifically provides adenoviral vector and plasmid constructs carrying polynucleotides encoding CEA fusion proteins and discloses their use in vaccines and pharmaceutical compositions for preventing and treating cancer.
Patent AU-2005247091-B2 (AU)
Title: Superloaded liposomes for drug delivery
Inventor: KUNERT RENATE
IPC: A61K9/127
Filed: 2005-05-24
Granted: 2010-08-12
Abstract: The present invention relates to liposomes for drug delivery, wherein a liposome includes molecules of at least one desired drug distributed within an aqueous phase in the interior of the liposome and wherein the liposome further includes molecules of the same or of another drug attached to either or both sides of the liposomal membrane. More specifically, the invention relates to liposomes, wherein at least a part of the molecules of a desired drug bear a functional group that is reactive with a functional group present in at least one lipid fraction, and wherein the drug is covalently linked to the membrane lipids by chemical bonding, e.g. by ester bonding of a hydroxyl group of a lipid molecule and an acidic residue of the drug. In a preferred embodiment, the desired drug is a glycoprotein such as erythropoietin. The invention further relates to a method of manufacture of said liposomes and to pharmaceutical compositions containing them.
Patent AU-2005269067-B2 (AU)
Title: Device and method for isolating cells, bioparticles and/or molecules from liquids for use with animals, in biotechnology, (including biotechnological research) and medical diagnostics
Inventor: HEINRICH HANS-WERNER
IPC: A61M1/36
Filed: 2005-07-29
Granted: 2012-02-16
Abstract: The invention relates to a device and a method for identifying and isolating specific bioparticles and also dissolved biomolecules from liquids, with the aid of suitable carriers and known immobilisation techniques. The device can be used both intermittently and also for the direct and continuous treatment of liquids. The invention can be used with animals, in biotechnology, (including biological research) and medical diagnostics.
Patent AU-2005272786-B2 (AU)
Title: Bisaryl-sulfonamides
Inventor: YOUNG STEPHEN C
IPC: C07D239/48
Filed: 2005-08-11
Granted: 2011-12-22
Abstract: Compounds, compositions and methods are provided that are useful in. the treatment or preventionTof a condition or disorder mediated by PPARγ or PPARδ. In particular, the compounds of the invention modulate the function of PPARγ or PPARδ. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis. The subject, compounds include bisaryl-sulfonamides that have general formula (I): wherein Ar, R, X, Y, Z. W, L, B and R are described herein.
Patent AU-2005309435-B2 (AU)
Title: Methods for improving liver clearance of xenobiotic substances in an animal
Inventor: CURTIS ZICKER STEVEN
IPC: A61K47/00
Filed: 2005-11-23
Granted: 2011-09-22
Abstract: A method for improving liver clearance of xenobiotic substances in an animal by feeding the animal lipoic acid in amounts of from about 10 mg to about 1000 mg per day.
Patent AU-2006236228-B2 (AU)
Title: Melt-bonded joint for medical devices
Inventor: PAL DHARMENDRA
IPC: A61F2/966
Filed: 2006-04-20
Granted: 2011-02-24
Abstract: Joint assemblies for joining sheaths for use in medical devices are provided, as are methods of manufacturing the joint assemblies. An elongate first sheath has a distal end portion having melt bonding material. A second sheath has first and second end portions, the second end portion having melt bonding material. An outer sleeve body includes proximal and distal engaging portions that have melt bonding materials. The proximal engaging portion is disposed about and melt bonded to the first sheath distal end portion. The distal engaging portion is disposed about and melt bonded to the second sheath proximal end portion. In one embodiment, one or both sheaths have an inner layer, a coiled middle layer optionally stopping short of the joint assembly, and an outer layer that has said melt bonding materials. In one embodiment, the sheaths are used in a rapid insertion catheter delivery system.
Patent AU-2006251860-B2 (AU)
Title: Improved bakery process
Inventor: EATON WILLETT PAUL
IPC: G06Q90/00
Filed: 2006-05-24
Granted: 2011-10-06
Abstract: A thawer for frozen dough including: an enclosure; at least one tray o conveyance for supporting at least one frozen dough piece within the enclosure; and a means to direct warm gas directly on to frozen sough within the enclosure. Also disclosed are: a method of producing a bread product by initially thawing a planer frozen dough piece; an apparatus for producing a bread product including a thawer; a planar frozen dough piece being elongate in shape and having a thickness within the range of 6-15mm; and, a method of thawing frozen dough.
Patent AU-2006267780-B2 (AU)
Title: Air bag device
Inventor: SEIICHIRO KAMURA
IPC: B60R21/231
Filed: 2006-05-09
Granted: 2011-07-07
Abstract: An air bag device enabling a reduction in an assembling working time for an air bag by securely holding the outer peripheral part and the peripheral edge part of the air bag by a holding member during the air bag assembling operation. The air bag device comprises the holding member (14) for suppressing the inflation and development of the air bag in the air bag side face direction by a gas generated from an inflator (30) at least at the beginning of the development of the air bag (10) by holding the air bag (10) in a foldably stored state and retaining the outer peripheral side-face of the air bag (10) and a gas flow straightening member (12) straightening and guiding the gas generated from the inflator (30) to near the portion of the air bag (10) inflated at the beginning of the development. The air bag device is characterized in that the holding member (14) is formed of a woven fabric and comprises a fracture planned part (14k) broken by the pressure of the gas generated from the inflator (30) at the portion of the woven fabric corresponding to the portion of the air bag (10) inflated at the beginning of the development.
Patent AU-2006343447-B2 (AU)
Title: Full face respiratory mask with integrated nasal interface
Inventor: EATON JASON P
IPC: G06Q50/00
Filed: 2006-12-06
Granted: 2011-08-11
Abstract: A patient interface (110, 210, 310, 410, 510, 610, 1000, 1050, HOO5 1150, 1300, 1350, 1370, 1400, 1500) that reliably and comfortably seals a user's face by providing an oral-nasal mask that includes an integrated nasal interface. The patient interface includes a seal member (114, 214, 314, 414, 514, 614, 714, 1004, 1054, 1104, 1154, 1200, 1250, 1304, 1354, 1374, 1404, 1504) having an oral cushion portion (122, 222, 322, 422, 522, 622, 722, 1010, 1060, 1106, 1156, 1202, 1252, 1306, 1356, 1406, 1506) configured to surround the user's mouth and a nasal interface portion (124, 224, 324, 424, 524, 624, 724, 1012, 1062, 1108, 1158, 1204, 1254, 1308, 1358, 1408, 1508) that provides an interface with the user's nose. The seal member, including the oral cushion portion and the nasal interface portion, is a unitary member. Finally, the nasal interface portion remains below the bridge of the nose.